rs2075558
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000088.4(COL1A1):c.2451+103T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.378 in 1,243,044 control chromosomes in the GnomAD database, including 96,932 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 10477 hom., cov: 31)
Exomes 𝑓: 0.38 ( 86455 hom. )
Consequence
COL1A1
NM_000088.4 intron
NM_000088.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.11
Publications
11 publications found
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A1 Gene-Disease associations (from GenCC):
- Caffey diseaseInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: MODERATE Submitted by: ClinGen
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-50190224-A-C is Benign according to our data. Variant chr17-50190224-A-C is described in ClinVar as Benign. ClinVar VariationId is 1268888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.765 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL1A1 | NM_000088.4 | c.2451+103T>G | intron_variant | Intron 35 of 50 | ENST00000225964.10 | NP_000079.2 | ||
| COL1A1 | XM_011524341.2 | c.2253+103T>G | intron_variant | Intron 32 of 47 | XP_011522643.1 | |||
| COL1A1 | XM_005257058.5 | c.2451+103T>G | intron_variant | Intron 35 of 48 | XP_005257115.2 | |||
| COL1A1 | XM_005257059.5 | c.1533+103T>G | intron_variant | Intron 22 of 37 | XP_005257116.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.354 AC: 53719AN: 151536Hom.: 10463 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
53719
AN:
151536
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.381 AC: 416358AN: 1091392Hom.: 86455 Cov.: 15 AF XY: 0.385 AC XY: 214498AN XY: 557764 show subpopulations
GnomAD4 exome
AF:
AC:
416358
AN:
1091392
Hom.:
Cov.:
15
AF XY:
AC XY:
214498
AN XY:
557764
show subpopulations
African (AFR)
AF:
AC:
5828
AN:
26594
American (AMR)
AF:
AC:
24320
AN:
43804
Ashkenazi Jewish (ASJ)
AF:
AC:
7063
AN:
23334
East Asian (EAS)
AF:
AC:
30464
AN:
37952
South Asian (SAS)
AF:
AC:
37422
AN:
78470
European-Finnish (FIN)
AF:
AC:
21400
AN:
52566
Middle Eastern (MID)
AF:
AC:
1463
AN:
5042
European-Non Finnish (NFE)
AF:
AC:
270559
AN:
775392
Other (OTH)
AF:
AC:
17839
AN:
48238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
14210
28420
42631
56841
71051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7360
14720
22080
29440
36800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.355 AC: 53774AN: 151652Hom.: 10477 Cov.: 31 AF XY: 0.366 AC XY: 27110AN XY: 74118 show subpopulations
GnomAD4 genome
AF:
AC:
53774
AN:
151652
Hom.:
Cov.:
31
AF XY:
AC XY:
27110
AN XY:
74118
show subpopulations
African (AFR)
AF:
AC:
9595
AN:
41282
American (AMR)
AF:
AC:
7082
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1116
AN:
3470
East Asian (EAS)
AF:
AC:
4012
AN:
5108
South Asian (SAS)
AF:
AC:
2349
AN:
4814
European-Finnish (FIN)
AF:
AC:
4362
AN:
10558
Middle Eastern (MID)
AF:
AC:
69
AN:
292
European-Non Finnish (NFE)
AF:
AC:
24264
AN:
67842
Other (OTH)
AF:
AC:
771
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1692
3384
5075
6767
8459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2128
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.